Gossamer Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Gossamer Bio
GOSS Stock  USD 1.42  0.03  2.16%   
Gossamer Bio financial statements provide useful quarterly and yearly information to potential Gossamer Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Gossamer Bio financial statements helps investors assess Gossamer Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Gossamer Bio's valuation are summarized below:
Gross Profit
114.7 M
Profit Margin
(0.49)
Market Capitalization
315 M
Enterprise Value Revenue
2.0657
Revenue
114.7 M
There are over one hundred nineteen available fundamental trends for Gossamer Bio, which can be analyzed over time and compared to other ratios. All traders should confirm Gossamer Bio's regular fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 589.3 M in 2025, whereas Market Cap is likely to drop slightly above 194.4 M in 2025.
Check Gossamer Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gossamer Bio's main balance sheet or income statement drivers, such as Interest Income of 1.6 M, Interest Expense of 8.7 M or Selling General Administrative of 36.8 M, as well as many indicators such as Price To Sales Ratio of 1.42, Dividend Yield of 0.0 or PTB Ratio of 7.29. Gossamer financial statements analysis is a perfect complement when working with Gossamer Bio Valuation or Volatility modules.
  
Check out the analysis of Gossamer Bio Correlation against competitors.
For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

Gossamer Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets299.4 M315.3 M171.8 M
Slightly volatile
Short and Long Term Debt Total145.2 M202.9 M77.5 M
Slightly volatile
Other Current Liabilities26.9 M41.7 M15.5 M
Slightly volatile
Total Current Liabilities34.6 M45 M19.9 M
Slightly volatile
Accounts Payable2.9 M2.3 M1.7 M
Slightly volatile
Cash43.8 M46.1 M71.5 M
Slightly volatile
Long Term Debt135.9 M197.5 M72.1 M
Slightly volatile
Cash And Short Term Investments283 M294.5 M162.4 M
Slightly volatile
Common Stock Shares Outstanding237.5 M226.2 M72.4 M
Slightly volatile
Long Term Debt Total34.4 M32.7 M15.3 M
Slightly volatile
Non Current Liabilities Total170.4 M240.8 M97.8 M
Slightly volatile
Total Liabilities205 M285.8 M117.7 M
Slightly volatile
Total Current Assets290.2 M309.9 M166.5 M
Slightly volatile
Other Liabilities867 K825.7 K375.5 K
Slightly volatile
Capital Surpluse659.2 M1.2 B406.3 M
Slightly volatile
Other Current Assets8.2 M10 M4.3 M
Slightly volatile
Property Plant And Equipment Net7.5 M5.1 M6.2 M
Slightly volatile
Other Assets0.860.92.7 M
Slightly volatile
Net Receivables6.4 M6.1 M1.9 M
Slightly volatile
Common Stock Total Equity7.7 K11.5 K5 K
Slightly volatile
Deferred Long Term Liabilities1.7 M1.9 M2.1 M
Slightly volatile
Property Plant And Equipment Gross9.3 M5.3 M7.3 M
Slightly volatile
Capital Stock27.8 K26.4 K8 K
Slightly volatile
Common Stock27.8 K26.4 K8 K
Slightly volatile
Property Plant Equipment5.4 M3.6 M4.5 M
Pretty Stable
Capital Lease Obligations5.8 M5.4 M9.3 M
Slightly volatile
Non Current Liabilities Other140.9 M229 M72.5 M
Slightly volatile
Short Term Debt913 K961 K3.8 M
Slightly volatile
Short and Long Term Debt9.3 M10.5 M11.4 M
Slightly volatile

Gossamer Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative36.8 M36.1 M21.2 M
Slightly volatile
Other Operating Expenses157.3 M174.6 M90.3 M
Slightly volatile
Total Operating Expenses157.3 M174.6 M90.3 M
Slightly volatile
Depreciation And Amortization3.3 M4.2 M4.6 M
Slightly volatile
Non Operating Income Net Other2.8 M2.8 M4.7 M
Slightly volatile
Selling And Marketing Expenses2.2 M2.5 M2.7 M
Slightly volatile

Gossamer Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow30.5 M32.1 M67.9 M
Slightly volatile
Other Cashflows From Financing Activities1 M1.1 M23.6 M
Very volatile
End Period Cash Flow43.8 M46.1 M71.6 M
Slightly volatile
Change To Netincome33.7 M48.9 M21.2 M
Slightly volatile
Stock Based Compensation29.5 M20.6 M15.2 M
Slightly volatile
Sale Purchase Of Stock597.5 K629 K204.1 M
Slightly volatile
Cash Flows Other Operating49.6 K52.2 K8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.421.611.7505
Slightly volatile
Days Sales Outstanding13.5915.2916.6682
Slightly volatile
Stock Based Compensation To Revenue0.140.160.176
Slightly volatile
Capex To Depreciation0.120.107240.7176
Slightly volatile
EV To Sales2.522.843.0924
Slightly volatile
Payables Turnover1.250.710.7754
Slightly volatile
Sales General And Administrative To Revenue0.260.280.3094
Slightly volatile
Research And Ddevelopement To Revenue0.971.091.1852
Slightly volatile
Cash Per Share2.61.30191.9907
Slightly volatile
Days Payables Outstanding7785291.7 K
Slightly volatile
Current Ratio5.626.88494.4591
Slightly volatile
Receivables Turnover17.1919.3421.0848
Slightly volatile
Capex Per Share0.00610.00650.2306
Slightly volatile
Revenue Per Share0.410.460.498
Slightly volatile
Interest Debt Per Share1.060.94770.8066
Slightly volatile
Debt To Assets0.610.64351.3792
Very volatile
Days Of Payables Outstanding7785291.7 K
Slightly volatile
Ebt Per Ebit1.110.92851.0179
Very volatile
Quick Ratio5.626.88494.4613
Slightly volatile
Net Income Per E B T0.820.910.995
Slightly volatile
Cash Ratio0.971.02362.1293
Slightly volatile
Days Of Sales Outstanding13.5915.2916.6682
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.231.151.27
Slightly volatile
Fixed Asset Turnover17.9220.1621.9784
Slightly volatile
Debt Ratio0.610.64351.3792
Very volatile
Price Sales Ratio1.421.611.7505
Slightly volatile
Asset Turnover0.290.330.3571
Slightly volatile

Gossamer Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap194.4 M204.6 M483.4 M
Pretty Stable
Enterprise Value589.3 M361.5 M505.3 M
Very volatile

Gossamer Fundamental Market Drivers

Cash And Short Term Investments294.5 M

Gossamer Upcoming Events

15th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Gossamer Bio Financial Statements

Gossamer Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Gossamer Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Gossamer Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Gossamer Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue114.7 M120.4 M
Cost Of Revenue5 M2.9 M
Stock Based Compensation To Revenue 0.16  0.14 
Sales General And Administrative To Revenue 0.28  0.26 
Research And Ddevelopement To Revenue 1.09  0.97 
Revenue Per Share 0.46  0.41 
Ebit Per Revenue(0.47)(0.49)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY